{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:56:02Z","timestamp":1778910962279,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Haemonetics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11239-016-1344-5","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T13:34:22Z","timestamp":1457098462000},"page":"233-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Y. C.","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ranjit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Blann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccl.2013.09.009","volume":"32","author":"L Liu","year":"2014","unstructured":"Liu L, Eisen HJ (2014) Epidemiology of heart failure and scope of the problem. Clin Cardiol 32:1\u20138","journal-title":"Clin Cardiol"},{"key":"1344_CR2","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/jama.2015.4369","volume":"313","author":"GY Lip","year":"2015","unstructured":"Lip GY, Lane DA (2015) Stroke prevention in atrial fibrillation: a systematic review. JAMA 313:1950\u20131962","journal-title":"JAMA"},{"key":"1344_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2012.07.064","volume":"61","author":"F Crea","year":"2013","unstructured":"Crea F, Liuzzo G (2013) Pathogenesis of acute coronary syndromes. J Am Coll Cardiol 61:1\u201311","journal-title":"J Am Coll Cardiol"},{"key":"1344_CR4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/17482940902934791","volume":"11","author":"ME Harinstein","year":"2009","unstructured":"Harinstein ME, Filippatos GS, Gheorghiade M (2009) Acute heart failure syndromes: epidemiology, risk stratification and prognostic factors. Acute Card Care. 11:77\u201382","journal-title":"Acute Card Care."},{"key":"1344_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2013.07.007","volume":"2","author":"PA Gurbel","year":"2014","unstructured":"Gurbel PA, Tantry US (2014) Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. JACC Heart Fail. 2:1\u201314","journal-title":"JACC Heart Fail."},{"key":"1344_CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/2047487312450228","volume":"19","author":"Fifth Joint Task Force of the European Society of Cardiology","year":"2012","unstructured":"Fifth Joint Task Force of the European Society of Cardiology (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur J Prev Cardiol 19:585\u2013667","journal-title":"Eur J Prev Cardiol"},{"issue":"366","key":"1344_CR7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","volume":"17","author":"S Homma","year":"2012","unstructured":"Homma S, Thompson JL, Pullicino PM, WARCEF Investigators et al (2012) Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 17(366):1859\u20131869","journal-title":"N Engl J Med"},{"key":"1344_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/europace\/eut083","volume":"15","author":"H Heidbuchel","year":"2013","unstructured":"Heidbuchel H, Verhamme P, Alings M et al (2013) European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15:625\u2013651","journal-title":"Europace"},{"key":"1344_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijlh.12004","volume":"35","author":"I Mackie","year":"2013","unstructured":"Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M, British Committee for Standards in Haematology (2013) Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol. 35:1\u201313","journal-title":"Int J Lab Hematol."},{"key":"1344_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.2011.08753.x","volume":"154","author":"D Keeling","year":"2011","unstructured":"Keeling D, Baglin T, Tait C et al (2011) British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin\u2014fourth edition. Br J Haematol 154:311\u2013324","journal-title":"Br J Haematol"},{"key":"1344_CR11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09674845.2014.11669981","volume":"71","author":"AD Blann","year":"2014","unstructured":"Blann AD (2014) Non-vitamin K antagonist oral anticoagulants (NOACs): a view from the laboratory. Br J Biomed Sci 71:158\u2013167","journal-title":"Br J Biomed Sci"},{"key":"1344_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2257.2005.00681.x","volume":"27","author":"RJ Luddington","year":"2005","unstructured":"Luddington RJ (2005) Thrombelastography\/thromboelastometry. Clin Lab Haematol 27:81\u201390","journal-title":"Clin Lab Haematol"},{"key":"1344_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-0038-1647336","volume":"64","author":"AJ Jones","year":"1990","unstructured":"Jones AJ, Meunier AM (1990) A precise and rapid\u00a0microtitre\u00a0plate\u00a0clot\u00a0lysis assay: methodology, kinetic modelling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 64:455\u2013463","journal-title":"Thromb Haemost"},{"key":"1344_CR14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.thromres.2013.12.035","volume":"133","author":"F Incampo","year":"2014","unstructured":"Incampo F, Carrieri C, Galasso R, Marino R, Ettorre CP, Semeraro N, Colucci M (2014) Co-administration of low molecular weight heparin enhances the profibrinolytic effect of warfarin through different mechanisms. Thromb Res 133:634\u2013639","journal-title":"Thromb Res"},{"key":"1344_CR15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vph.2015.02.013","volume":"71","author":"P Ranjit","year":"2015","unstructured":"Ranjit P, Lau Y, Lip GY, Blann AD (2015) Development and validation of a new assay for assessing clot integrity. Vasc Pharmacol 71:102\u2013107","journal-title":"Vasc Pharmacol"},{"issue":"Suppl 4","key":"1344_CR16","first-page":"59","volume":"21","author":"CI Traverso","year":"1995","unstructured":"Traverso CI, Arcelus JI, Caprini JA (1995) Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine. Semin Thromb Hemost 21(Suppl 4):59\u201362","journal-title":"Semin Thromb Hemost"},{"key":"1344_CR17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5858\/arpa.2014-0170-OA","volume":"139","author":"JD Dias","year":"2015","unstructured":"Dias JD, Norem K, Doorneweerd DD, Thurer RL, Popovsky MA, Omert LA (2015) Use of thromboelastography (TEG) for detection of new oral anticoagulants. Arch Pathol Lab Med 139:665\u2013673","journal-title":"Arch Pathol Lab Med"},{"key":"1344_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1160\/TH10-12-0785","volume":"106","author":"A Darlington","year":"2011","unstructured":"Darlington A, Ferreiro JL, Ueno M et al (2011) Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease. Thromb Haemost 106:67\u201374","journal-title":"Thromb Haemost"},{"key":"1344_CR19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11239-014-1130-1","volume":"40","author":"F Franchi","year":"2015","unstructured":"Franchi F, Hammad JS, Rollini F, Tello-Montoliu A, Patel R, Darlington A et al (2015) Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists. J Thromb Thrombolysis 40:118\u2013125","journal-title":"J Thromb Thrombolysis"},{"key":"1344_CR20","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","volume":"24","author":"AD Blann","year":"2003","unstructured":"Blann AD, Nadar SK, Lip GY (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24:2166\u20132179","journal-title":"Eur Heart J"},{"key":"1344_CR21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/TA.0b013e3182a9676c","volume":"75","author":"SP McCully","year":"2013","unstructured":"McCully SP, Fabricant LJ, Kunio NR et al (2013) The International Normalized Ratio overestimates coagulopathy in stable trauma and surgical patients. J Trauma Acute Care Surg. 75:947\u2013953","journal-title":"J Trauma Acute Care Surg."},{"key":"1344_CR22","volume-title":"Practical statistics for medical research","author":"DG Altman","year":"1991","unstructured":"Altman DG (1991) Practical statistics for medical research. Chapman and Hall, London"},{"key":"1344_CR23","volume-title":"Statistical table for the design of clinical trials","author":"D Machin","year":"1987","unstructured":"Machin D, Campbell M (1987) Statistical table for the design of clinical trials. Blackwell Scientific, Oxford"},{"key":"1344_CR24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1309\/AJCPVB73TMIDFNCB","volume":"142","author":"KJ Welsh","year":"2014","unstructured":"Welsh KJ, Padilla A, Dasgupta A, Nguyen AN, Wahed A (2014) Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state. Am J Clin Pathol 142:492\u2013497","journal-title":"Am J Clin Pathol"},{"key":"1344_CR25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/TA.0000000000000165","volume":"76","author":"SG Louis","year":"2014","unstructured":"Louis SG, Van PY, Riha GM et al (2014) Thromboelastogram-guided enoxaparin dosing does not confer protection from deep venous thrombosis: a randomized controlled pilot trial. J Trauma Acute Care Surg. 76:937\u2013942","journal-title":"J Trauma Acute Care Surg."},{"key":"1344_CR26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00277-015-2399-7","volume":"94","author":"J Gebhart","year":"2015","unstructured":"Gebhart J, Laczkovics C, Posch F, Ay C, Reitter-Pfoertner SE, Haslacher H, Muszbek L, Wolberg AS, Pabinger I (2015) Plasma\u00a0clot\u00a0properties in patients with a mild-to-moderate bleeding tendency of unknown cause. Ann Hematol 94:1301\u20131310","journal-title":"Ann Hematol"},{"key":"1344_CR27","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1160\/TH12-02-0124","volume":"108","author":"S Talens","year":"2012","unstructured":"Talens S, Malfliet JJ, Rude\u017e G, Spronk HM, Janssen NA, Meijer P, Kluft C, de Maat MP, Rijken DC (2012) Biological variation in tPA-induced plasma clot lysis time. Thromb Haemost 108:640\u2013646","journal-title":"Thromb Haemost"},{"key":"1344_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.08.007","author":"M Z\u0105bczyk","year":"2015","unstructured":"Z\u0105bczyk M, Majewski J, Karkowski G, Malinowski KP, Undas A (2015) Vitamin K antagonists favourably modulate\u00a0fibrin\u00a0clot\u00a0properties in patients with atrial fibrillation as early as after 3\u00a0days of treatment: Relation to coagulation factors and thrombin generation. Thromb Res. doi: 10.1016\/j.thromres.2015.08.007","journal-title":"Thromb Res"},{"key":"1344_CR29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00001721-199909000-00009","volume":"10","author":"F Warzok","year":"1999","unstructured":"Warzok F, Steiner M, Blann AD, Weber F, Urbaszek W, Schuff-Werner P (1999) Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease. Blood Coagul Fibrinolysis 10:381\u2013387","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1344_CR30","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9149(99)00098-3","volume":"83","author":"CM O\u2019Connor","year":"1999","unstructured":"O\u2019Connor CM, Gurbel PA, Serebruany VL (1999) Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol 83:1345\u20131349","journal-title":"Am J Cardiol"},{"key":"1344_CR31","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jacc.2007.02.038","volume":"49","author":"A Choudhury","year":"2007","unstructured":"Choudhury A, Chung I, Blann AD, Lip GY (2007) Platelet surface CD62P and CD63, mean platelet volume, and soluble\/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of \u201chealthy control subjects\u201d and \u201cdisease control subjects\u201d in sinus rhythm. J Am Coll Cardiol 49:1957\u20131964","journal-title":"J Am Coll Cardiol"},{"key":"1344_CR32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09537105310001645960","volume":"15","author":"IA Jagroop","year":"2004","unstructured":"Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP (2004) The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets 15:117\u2013125","journal-title":"Platelets"},{"key":"1344_CR33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11239-015-1179-5","volume":"40","author":"V Valdes","year":"2015","unstructured":"Valdes V, Nardi MA, Elbaum L, Berger JS (2015) Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand. J Thromb Thrombolysis 40:83\u201387","journal-title":"J Thromb Thrombolysis"},{"key":"1344_CR34","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/clinchem\/44.8.1845","volume":"44","author":"J Fareed","year":"1998","unstructured":"Fareed J, Hoppensteadt DA, Leya F, Iqbal O, Wolf H, Bick R (1998) Useful laboratory tests for studying\u00a0thrombogenesis\u00a0in acute cardiac syndromes. Clin Chem 44:1845\u20131853","journal-title":"Clin Chem"},{"key":"1344_CR35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.94.3.425","volume":"94","author":"GY Lip","year":"1996","unstructured":"Lip GY, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, Beevers DG (1996) Fibrin D-dimer and\u00a0beta-thromboglobulin\u00a0as markers of\u00a0thrombogenesis\u00a0and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 94:425\u2013431","journal-title":"Circulation"},{"key":"1344_CR36","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/TA.0b013e3182826d7e","volume":"74","author":"JN Harr","year":"2013","unstructured":"Harr JN, Moore EE, Chin TL et al (2013) Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg. 74:756\u2013762","journal-title":"J Trauma Acute Care Surg."},{"key":"1344_CR37","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.thromres.2013.07.012","volume":"132","author":"D Lu","year":"2013","unstructured":"Lu D, Owens J, Kreutz RP (2013) Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes. Thromb Res 132:e94\u2013e98","journal-title":"Thromb Res"},{"key":"1344_CR38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11239-013-0933-9","volume":"37","author":"R Neyens","year":"2014","unstructured":"Neyens R, Bohm N, Cearley M, Andrews C, Chalela J (2014) Dabigatran-associated subdural hemorrhage: using thromboelastography (TEG(\u00ae)) to guide decision-making. J Thromb Thrombolysis 37:80\u201383","journal-title":"J Thromb Thrombolysis"},{"key":"1344_CR39","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/j.1538-7836.2011.04488.x","volume":"9","author":"MM Aleman","year":"2011","unstructured":"Aleman MM, Gardiner C, Harrison P, Wolberg AS (2011) Differential contributions of monocyte- and\u00a0platelet-derived\u00a0microparticles\u00a0towards thrombin generation and fibrin formation and stability. J Thromb Haemost 9:2251\u20132261","journal-title":"J Thromb Haemost"},{"key":"1344_CR40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MBC.0b013e32833a9035","volume":"21","author":"A Undas","year":"2010","unstructured":"Undas A, Nycz K, Pastuszczak M, Stompor T, Zmudka K (2010) The effect of chronic kidney disease on fibrin clot properties in patients with acute coronary syndrome. Blood Coagul Fibrinolysis 21:522\u2013527","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1344-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1344-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T16:43:24Z","timestamp":1600274604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1344-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1344-5","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}